DK1007047T3 - Anvendelse af mizolastin til fremstilling af et lægemiddel beregnet til inflammationsbehandling - Google Patents

Anvendelse af mizolastin til fremstilling af et lægemiddel beregnet til inflammationsbehandling

Info

Publication number
DK1007047T3
DK1007047T3 DK98921544T DK98921544T DK1007047T3 DK 1007047 T3 DK1007047 T3 DK 1007047T3 DK 98921544 T DK98921544 T DK 98921544T DK 98921544 T DK98921544 T DK 98921544T DK 1007047 T3 DK1007047 T3 DK 1007047T3
Authority
DK
Denmark
Prior art keywords
pct
mizolastine
inflammation
manufacture
treatment
Prior art date
Application number
DK98921544T
Other languages
English (en)
Inventor
Sonia Arbilla
Luc Even
Nigel Roome
Itzchak Angel
Jon Goldhill
Philippe Pichat
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Application granted granted Critical
Publication of DK1007047T3 publication Critical patent/DK1007047T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK98921544T 1997-04-17 1998-04-16 Anvendelse af mizolastin til fremstilling af et lægemiddel beregnet til inflammationsbehandling DK1007047T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9704801A FR2762214B1 (fr) 1997-04-17 1997-04-17 Utilisation de la mizolastine pour la preparation d'un medicament destine au traitement de l'inflammation

Publications (1)

Publication Number Publication Date
DK1007047T3 true DK1007047T3 (da) 2006-05-08

Family

ID=9506075

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98921544T DK1007047T3 (da) 1997-04-17 1998-04-16 Anvendelse af mizolastin til fremstilling af et lægemiddel beregnet til inflammationsbehandling

Country Status (11)

Country Link
US (1) US6140335A (da)
EP (1) EP1007047B1 (da)
JP (2) JP2001523242A (da)
AT (1) ATE312611T1 (da)
AU (1) AU7436098A (da)
DE (1) DE69832796T2 (da)
DK (1) DK1007047T3 (da)
ES (1) ES2253816T3 (da)
FR (1) FR2762214B1 (da)
WO (1) WO1998047511A1 (da)
ZA (1) ZA983211B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0958820A1 (en) * 1998-05-19 1999-11-24 Sanofi-Synthelabo Use of an imidazol derivative for the manufacture of a medicament for treating auto-immunodiseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2587029B1 (fr) * 1985-09-11 1987-10-30 Synthelabo Derives de benzimidazole, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
AU7436098A (en) 1998-11-13
JP2001523242A (ja) 2001-11-20
JP2009292827A (ja) 2009-12-17
DE69832796D1 (de) 2006-01-19
EP1007047B1 (fr) 2005-12-14
US6140335A (en) 2000-10-31
WO1998047511A1 (fr) 1998-10-29
ZA983211B (en) 1998-10-22
ATE312611T1 (de) 2005-12-15
JP5271188B2 (ja) 2013-08-21
DE69832796T2 (de) 2006-08-31
FR2762214B1 (fr) 2000-10-06
EP1007047A1 (fr) 2000-06-14
ES2253816T3 (es) 2006-06-01
FR2762214A1 (fr) 1998-10-23

Similar Documents

Publication Publication Date Title
DK0758241T3 (da) Anvendelse af visse methanbisphosphonsyrederivater til at hindre løsning og vandring af proteser
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
ID22746A (id) Senyawa-senyawa baru
ES2192839T3 (es) Timosina beta 4 oxidada.
KR960701051A (ko) 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases)
BG106095A (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
NO20101190L (no) Anvendelse av buprenorfin i fremstillingen av et medikament
DK0867184T3 (da) Anvendelse af tiagabin til behandling af søvnforstyrrelser
ATE202478T1 (de) Neues pharmazeutisches präparat zur schmerzbehandlung
BR9809185A (pt) Diidropiranos fundidos
DK0998287T3 (da) Anvendelse af levobupivacain
NO994431L (no) Ny formulering
DK0946162T3 (da) Anvendelse af p-aminophenol-derivater til fremstilling af farmaceutiske præparater, som er nyttige til behandlingen af neurodegenerative sygdomme
RS50148B (sr) Upotreba docetaksela za lečenje hepatoćelijskog karcinoma
ATE319473T1 (de) Melagatran zur behandlung von entzündungen
GB0020504D0 (en) Therapeutic method
TR200200278T2 (tr) Kalsilitik bileşimler
GB9227123D0 (en) Method
NO990450L (no) Behandling av sinnslidelser
DK1007047T3 (da) Anvendelse af mizolastin til fremstilling af et lægemiddel beregnet til inflammationsbehandling
DK1244438T3 (da) Anvendelse af beta-adrenoceptorantagonister til fremstilling af et medikament til behandling af sygdomme i den ydre nethinde
TR199500984A2 (tr) Selegilin'in epileptik hastaliklarin tedavisinde kullanimi.
AR023464A1 (es) Usos novedosos de la proteina ox2 de mamifero y reactivos relacionados
ATE341323T1 (de) Verwendung von darifenacin zur behandlung des harndrangs
TR199801801T2 (xx) Madde k�t�ye kullan�m�n�n tedavisi.